- Report
- October 2024
- 187 Pages
Global
From €3348EUR$3,545USD£2,848GBP
€3720EUR$3,939USD£3,164GBP
- Report
- March 2025
- 200 Pages
Global
From €4240EUR$4,490USD£3,607GBP
- Report
- May 2024
- 139 Pages
Global
From €6138EUR$6,499USD£5,220GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1417EUR$1,500USD£1,205GBP
- Report
- February 2024
- 70 Pages
India
From €4486EUR$4,750USD£3,815GBP
- Report
- November 2020
- 225 Pages
Global
From €14161EUR$14,995USD£12,045GBP
- Report
- April 2025
- 50 Pages
Global
From €2503EUR$2,650USD£2,129GBP
Bromocriptine is a drug used to treat endocrine and metabolic disorders. It is a dopamine agonist, meaning it works by activating dopamine receptors in the body. It is used to treat conditions such as acromegaly, hyperprolactinemia, and type 2 diabetes. It is also used to treat Parkinson's disease and other neurological disorders. Bromocriptine is available in both oral and injectable forms.
Bromocriptine is a widely used drug in the endocrine and metabolic disorders market. It is used to treat a variety of conditions, including acromegaly, hyperprolactinemia, and type 2 diabetes. It is also used to treat Parkinson's disease and other neurological disorders.
Some companies in the Bromocriptine market include Novartis, Pfizer, Merck, and Sanofi. Show Less Read more
